Form 4 for CRVL CORVEL CORP
Accepted 2023-03-15 00:00:00 ET · period of report 2023-03-13 · accession 0001754499-23-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-15 | 2023-03-13 | CRVL | O'Brien Brandon | CFO | M - OptEx | $77.93 | +2,036 | 5,182 | +65% | +$158.7K |
| DM | 2023-03-15 | 2023-03-13 | CRVL | O'Brien Brandon | CFO | S - Sale+OE | $176.75 | -2,036 | 3,182 | -39% | -$359.9K |
| DM | 2023-03-15 | 2023-03-13 | CRVL | O'Brien Brandon | CFO | M - OptEx | $0.00 | -2,036 | 42 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-13 | M | A | 16 | $87.49 | 3,198 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-13 | S | D | 16 | $176.75 | 3,182 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-13 | M | A | 20 | $70.24 | 3,202 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-13 | S | D | 20 | $176.75 | 3,182 | D | — | — | |
| 5 | Common | Common Stock | 2023-03-13 | S | D | 2,000 | $176.75 | 3,182 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-13 | M | A | 2,000 | $77.93 | 5,182 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-13 | M | D | 20 | $0.00 | 42 | D | $70.24 · — to 2024-04-25 | 20 Common Stock | (F1) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-13 | M | D | 2,000 | $0.00 | 3,832 | D | $77.93 · — to 2024-11-05 | 2,000 Common Stock | (F2) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-13 | M | D | 16 | $0.00 | 42 | D | $87.49 · — to 2024-08-08 | 16 Common Stock | (F1) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |